Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC

Title
Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC
Authors
Keywords
-
Journal
Cancer Discovery
Volume -, Issue -, Pages candisc.0369.2021
Publisher
American Association for Cancer Research (AACR)
Online
2021-08-05
DOI
10.1158/2159-8290.cd-21-0369

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started